AIM ImmunoTech Inc (AIM)

2.58 -0.09  -3.37% NYSE AM Jul 10, 13:11 Real time USD
View Full Chart
Price Chart
View All Events


Date Type Description
08/17/2020 Earnings AIM ImmunoTech Inc Second Quarter Earnings Results for 2020
05/14/2020 Earnings AIM ImmunoTech Inc First Quarter Earnings Results for 2020
03/31/2020 Earnings AIM ImmunoTech Inc Fourth Quarter Earnings Results for 2019
03/30/2020 Misc AIM ImmunoTech Inc Annual Report for 2019
10/03/2019 10:00 EDT Misc AIM ImmunoTech Inc Annual General Meeting for 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • URL:
  • Investor Relations URL:
  • HQ State/Province: Florida
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Aug. 17, 2020
  • Last Earnings Release: May. 14, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: AIM ImmunoTech Inc is a US-based specialty pharmaceutical company. It is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based disorders. The products of the firm are Alferon N Injection and the experimental therapeutic Ampligen. Alferon N Injection is approved for a category of STD infection, and Ampligen represents a RNA being developed for viral diseases and disorders of the immune system. The sales revenue of the company is derived from the United States.





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.